Targeting survivin in cancer therapy

By Pennati Marzia   Folini Marco   Zaffaroni Nadia  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 4, 2008-04 ,pp. : 463-476

Informa Healthcare

Access to resources Recommend Favorite

Prostate cancer: therapeutic patent review

By Sepp-Lorenzino L.   Slovin S.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. : 1833-1842

Informa Healthcare

Access to resources Recommend Favorite

Influence of SiRNA Targeting Survivin on Chemosensitivity of H460/cDDP Lung Cancer Cells

By Yang H   Fu J-H   Hu Y   Huang W-Z   Zheng B   Wang G   Zhang X   Wen J  

The Journal of International Medical Research, Vol. 36, Iss. 4, 2008-07 ,pp. : 734-747

Field House Publishing

Access to resources Recommend Favorite

Dendrimer and cancer: a patent review (2006 – present)

By Cai Xiaopan   Hu Jingjing   Xiao Jianru   Cheng Yiyun  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 515-529

Informa Healthcare

Access to resources Recommend Favorite

Kinesin spindle protein inhibitors in cancer: a patent review (2008 – present)

By Jiang Cheng   You Qidong  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1547-1560

Informa Healthcare

Access to resources Recommend Favorite